Source:http://linkedlifedata.com/resource/pubmed/id/12077187
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2002-6-21
|
pubmed:abstractText |
Spinocerebellar ataxia (SCA) type 7 is an inherited neurodegenerative disorder caused by expansion of a polyglutamine tract within the ataxin-7 protein. To determine the molecular basis of polyglutamine neurotoxicity in this and other related disorders, we produced SCA7 transgenic mice that express ataxin-7 with 24 or 92 glutamines in all neurons of the CNS, except for Purkinje cells. Transgenic mice expressing ataxin-7 with 92 glutamines (92Q) developed a dramatic neurological phenotype presenting as a gait ataxia and culminating in premature death. Despite the absence of expression of polyglutamine-expanded ataxin-7 in Purkinje cells, we documented severe Purkinje cell degeneration in 92Q SCA7 transgenic mice. We also detected an N-terminal truncation fragment of ataxin-7 in transgenic mice and in SCA7 patient material with both anti-ataxin-7 and anti-polyglutamine specific antibodies. The appearance of truncated ataxin-7 in nuclear aggregates correlates with the onset of a disease phenotype in the SCA7 mice, suggesting that nuclear localization and proteolytic cleavage may be important features of SCA7 pathogenesis. The non-cell-autonomous nature of the Purkinje cell degeneration in our SCA7 mouse model indicates that polyglutamine-induced dysfunction in adjacent or connecting cell types contributes to the neurodegeneration.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1529-2401
|
pubmed:author |
pubmed-author:EinumDavid DDD,
pubmed-author:FineGabriel CGC,
pubmed-author:FuYing-HuiYH,
pubmed-author:GardenGwenn AGA,
pubmed-author:GroteSara KSK,
pubmed-author:HuangJingJ,
pubmed-author:KinoshitaYoshitoY,
pubmed-author:La SpadaAlbert RAR,
pubmed-author:LibbyRandell TRT,
pubmed-author:MartinezRefugio ARA,
pubmed-author:MorrisonRichard SRS,
pubmed-author:PossinDaniel EDE,
pubmed-author:PtacekLouis JLJ,
pubmed-author:SmithAnnette CAC,
pubmed-author:SopherBryce LBL,
pubmed-author:WareCarol BCB
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4897-905
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12077187-Animals,
pubmed-meshheading:12077187-Cell Nucleus,
pubmed-meshheading:12077187-Gait Ataxia,
pubmed-meshheading:12077187-Inclusion Bodies,
pubmed-meshheading:12077187-Kinetics,
pubmed-meshheading:12077187-Mice,
pubmed-meshheading:12077187-Mice, Transgenic,
pubmed-meshheading:12077187-Mutation,
pubmed-meshheading:12077187-Nerve Tissue Proteins,
pubmed-meshheading:12077187-Peptides,
pubmed-meshheading:12077187-Purkinje Cells,
pubmed-meshheading:12077187-Spinocerebellar Degenerations
|
pubmed:year |
2002
|
pubmed:articleTitle |
Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
|
pubmed:affiliation |
Department of Neurology, University of Washington Medical Center, Seattle, Washington 98195-7110, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|